These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33459877)

  • 1. The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach.
    Clark SD
    Handb Exp Pharmacol; 2022; 271():525-546. PubMed ID: 33459877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder.
    Browne CA; Wulf H; Lucki I
    Handb Exp Pharmacol; 2022; 271():493-524. PubMed ID: 33580854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
    Anderson RI; Becker HC
    Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
    Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
    Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine.
    Quintanilla B; Medeiros GC; Greenstein D; Yuan P; Johnston JN; Park LT; Goes FS; Gould TD; Zarate CA
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):89-96. PubMed ID: 36821406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.
    Clark SD; Abi-Dargham A
    Biol Psychiatry; 2019 Oct; 86(7):502-511. PubMed ID: 31376930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders.
    Jacobson ML; Browne CA; Lucki I
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():615-636. PubMed ID: 31914893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.
    Tejeda HA; Wang H; Flores RJ; Yarur HE
    Handb Exp Pharmacol; 2022; 271():223-253. PubMed ID: 33580392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationships of [des-Arg
    Ramos-Colon CN; Lee YS; Remesic M; Hall SM; LaVigne J; Davis P; Sandweiss AJ; McIntosh MI; Hanson J; Largent-Milnes TM; Vanderah TW; Streicher J; Porreca F; Hruby VJ
    J Med Chem; 2016 Nov; 59(22):10291-10298. PubMed ID: 27797517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.
    Erikson CM; Wei G; Walker BM
    Neuropharmacology; 2018 Sep; 140():162-173. PubMed ID: 30075159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the kappa opioid receptor system in opioid use.
    Cayir S; Zhornitsky S; Barzegary A; Sotomayor-Carreño E; Sarfo-Ansah W; Funaro MC; Matuskey D; Angarita G
    Neurosci Biobehav Rev; 2024 Jul; 162():105713. PubMed ID: 38733895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insula Dynorphin and Kappa Opioid Receptor Systems Regulate Alcohol Drinking in a Sex-Specific Manner in Mice.
    Pina MM; Pati D; Neira S; Taxier LR; Stanhope CM; Mahoney AA; D'Ambrosio S; Kash TL; Navarro M
    J Neurosci; 2023 Jul; 43(28):5158-5171. PubMed ID: 37217307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors.
    Kissler JL; Sirohi S; Reis DJ; Jansen HT; Quock RM; Smith DG; Walker BM
    Biol Psychiatry; 2014 May; 75(10):774-82. PubMed ID: 23611261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders.
    Reed B; Butelman ER; Kreek MJ
    Handb Exp Pharmacol; 2022; 271():473-491. PubMed ID: 33174064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanine scan of the opioid peptide dynorphin B amide.
    Joshi AA; Murray TF; Aldrich JV
    Biopolymers; 2017 Sep; 108(5):. PubMed ID: 28464209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.
    Svingos AL; Colago EE; Pickel VM
    J Neurosci; 1999 Mar; 19(5):1804-13. PubMed ID: 10024364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
    Carlezon WA; Krystal AD
    Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.